MyFinsight
Home
Blog
About
Contact
Download
Download image
Prepaid expenses and
other current assets
$8,438K
Accounts receivable
$6,542K
Marketable securities,
current
$133,075K
Cash and cash
equivalents
$58,809K
Other assets
$211K
Restricted cash
$3,443K
Right-of-use asset
$41,961K
Property and equipment,
net
$5,134K
Marketable securities,
non-current
$7,875K
Total current assets
$206,864K
Total assets
$265,488K
Total liabilities and
stockholders equity
$265,488K
Total stockholders
equity
$154,408K
Total liabilities
$111,080K
Accumulated deficit
-$718,207K
Accumulated other
comprehensive income
$87K
Additional paid-in capital
$872,521K
Operating lease
liability, net of current
$55,247K
Deferred revenue, net of
current
$19,888K
Total current
liabilities
$35,945K
Common stock, par value
of 0.0001 per share...
$7K
Operating lease
liability, current
$6,216K
Deferred revenue,
current
$17,126K
Accrued expenses and
other current...
$11,270K
Accounts payable
$1,333K
Back
Back
Balance Sheet
source: myfinsight.com
C4 Therapeutics, Inc. (CCCC)
C4 Therapeutics, Inc. (CCCC)